ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,247Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 300

$1.67M Total Retail Price of All Prescriptions

Rank: 2 out of 300

880 Patients Receiving at Least One Drug in Part D
25%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

73% of this provider’s 880 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

58% of this provider’s 880 patients filled at least one prescription for a schedule three drug, compared to an average of 21%.

Risky Drugs to Seniors

7% of this provider’s 3,735 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 5%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$87 was the average price of a prescription from this provider, compared to $75 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 3,504 908 S3 1 1
MORPHINE SULFATE ER 1,916 348 S2 10 2 19
CARISOPRODOL 1,403 177 R 3 28
GABAPENTIN 1,334 306 4 6
TIZANIDINE HCL 988 142 5 10
OXYCODONE HCL-ACETAMINOPHEN 847 176 S2 6 48
TRAMADOL HCL 667 166 7 11
ZOLPIDEM TARTRATE 616 98 8 16
METHADONE HCL 592 151 S2 9 25
MORPHINE SULFATE 561 107 S2 10 65
ENDOCET 508 71 S2 11 60
OXYCODONE HCL 504 125 S2 12 22
LYRICA 419 72 13 31
FENTANYL 373 80 S2 14 38
PROMETHAZINE HCL 330 27 R 15 58
SAVELLA 330 28 10 15 185
LIDODERM 329 75 17 160
MELOXICAM 315 44 18 14
OPANA ER 260 13 S2 19 136
CYCLOBENZAPRINE HCL 252 39 R 20 35
CYMBALTA 172 17 21 54
NAMENDA 168 32 22 61
OXYCONTIN 158 70 S2 23 37
VIIBRYD 146 0 24 270
LUNESTA 117 13 25 194
OXYCODONE-ACETAMINOPHEN 115 46 S2 26 108
VOLTAREN 105 0 27 235
TRAZODONE HCL 98 0 28 51
AMITRIPTYLINE HCL 91 17 R 29 43
EXALGO 89 13 S2 30 313
BUSPIRONE HCL 88 0 31 214
BUTALBITAL COMPOUND-CODEINE 70 0 S3 R 10 32 333
HYDROMORPHONE HCL 67 15 S2 33 187
NUCYNTA 65 0 S2 34 339
SERTRALINE HCL 65 0 34 40
IBUPROFEN 64 14 36 142
OXYMORPHONE HCL 62 0 S2 37 342
FENTORA 61 17 S2 10 38 346
NUVIGIL 57 11 39 294
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.